Quiet on the insider front: nobody at Tourmaline Bio, Inc. bought or sold TRML shares with their own money this past year.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | Kulkarni Sandeep Chidambar | CEO | Buy | 1,779 | $14.85 | $26K | SEC |
| Aug 20, 2024 | Kulkarni Sandeep Chidambar | CEO | Buy | 5,221 | $13.79 | $72K | SEC |
| Jan 31, 2024 | MCDADE MARK | Director | Buy | 100,000 | $32.50 | $3.2M | SEC |
| Nov 20, 2023 | Kulkarni Sandeep Chidambar | CEO | Buy | 4,000 | $16.99 | $68K | SEC |
| Nov 20, 2023 | Thiara Parvinder | Director | Buy | 1,000 | $17.31 | $17K | SEC |
| Oct 27, 2023 | Castelein Caley | Director | Buy | 4,200 | $12.07 | $51K | SEC |
| Oct 27, 2023 | Castelein Caley | Director | Buy | 15,800 | $14.55 | $230K | SEC |
| Oct 26, 2023 | Kulkarni Sandeep Chidambar | CEO | Buy | 4,650 | $10.68 | $50K | SEC |
| Oct 26, 2023 | Kulkarni Sandeep Chidambar | CEO | Buy | 5,000 | $12.25 | $61K | SEC |
| Oct 26, 2023 | KANTOFF AARON | Director | Buy | 7,500 | $11.86 | $89K | SEC |
| Oct 26, 2023 | Thiara Parvinder | Director | Buy | 2,000 | $12.12 | $24K | SEC |
| Oct 26, 2023 | Thiara Parvinder | Director | Buy | 5,000 | $10.66 | $53K | SEC |
There were no open-market insider trades in TRML in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in TRML were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).